Sharon Mates, Intra-Cellular Therapies CEO
March 28, 2023 11:12 AM EDT
R&D

In­tra-Cel­lu­lar Ther­a­pies gets a boost on PhI­II de­pres­sion drug da­ta

Tyler Patchen

News Reporter

Biotech In­tra-Cel­lu­lar Ther­a­pies tout­ing new da­ta Tues­day for its drug de­signed to treat ma­jor de­pres­sive dis­or­der.

The biotech shared re­sults from …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times